"The Prevalence of Cyclin-Dependent Kinase 4/6 Inhibitors Induced Rashes Among Females with Breast Cancer" Datasheet

Name: "The Prevalence of Cyclin-Dependent Kinase 4/6 Inhibitors Induced Rashes Among Females with Breast Cancer" Datasheet
Creator: Senani, Mohammed; Al-khudeer, Abdullah; Alhusaini, Yousef; Alkaff, Abdulrahman; Ishgi, Ali; Al-Mansour, Mubarak; Jfri, Abdulhadi
Published: 2025-09-29 00:00:00
License: 暂无描述

Figshare2025-09-29 更新2026-04-08 收录

下载链接：

https://figshare.com/articles/dataset/_The_Prevalence_of_Cyclin-Dependent_Kinase_Inhibitors_Induced_Rashes_Among_Females_with_Breast_Cancer_Datasheet/27131280/1

下载链接

链接失效反馈

官方服务：

资源简介：

Cyclin-dependent kinase (CDK) 4/6 inhibitors including palbociclib, ribociclib, and abemaciclib, are used for treating advanced breast cancer in combination with anti-hormonal therapy and can lead to cutaneous adverse events (cAEs). This retrospective single-center cross-sectional study conducted at the Princess Noorah Oncology Center in Jeddah, Saudi Arabia, investigated the prevalence of cAEs in female breast cancer patients treated with CDK 4/6 inhibitors. Using electronic medical records, data was collected and analyzed for cAE prevalence, phenotype, treatment outcomes, and risk factors.

提供机构：

Senani, Mohammed; Al-khudeer, Abdullah; Alhusaini, Yousef; Alkaff, Abdulrahman; Ishgi, Ali; Al-Mansour, Mubarak; Jfri, Abdulhadi

创建时间：

2024-10-01